Barclays’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2015
Q4 | – | Sell |
-149,583
| Closed | -$6.43M | – | 4243 |
|
2015
Q3 | $6.43M | Hold |
149,583
| – | – | 0.01% | 619 |
|
2015
Q2 | $6.28M | Sell |
149,583
-26,189
| -15% | -$1.1M | 0.01% | 721 |
|
2015
Q1 | $6.68M | Sell |
175,772
-24,561
| -12% | -$933K | 0.01% | 781 |
|
2014
Q4 | $6.61M | Buy |
200,333
+15,368
| +8% | +$507K | 0.01% | 798 |
|
2014
Q3 | $6.47M | Buy |
184,965
+59
| +0% | +$2.07K | 0.01% | 844 |
|
2014
Q2 | $5.92M | Buy |
184,906
+52,136
| +39% | +$1.67M | 0.01% | 871 |
|
2014
Q1 | $4.78M | Buy |
132,770
+63,086
| +91% | +$2.27M | 0.01% | 947 |
|
2013
Q4 | $2.65M | Buy |
69,684
+27,284
| +64% | +$1.04M | ﹤0.01% | 1262 |
|
2013
Q3 | $1.15M | Buy |
42,400
+26,800
| +172% | +$724K | ﹤0.01% | 1621 |
|
2013
Q2 | $328K | Buy |
+15,600
| New | +$328K | ﹤0.01% | 2450 |
|